
Hosted by StartUp Health NOW Podcast · EN

What does the senior CMS official focused on payment and delivery innovation actually want health tech founders to understand? In this episode, we listen in on highlights from a recent fireside chat as StartUp Health co-founder Unity Stoakes talks with Abe Sutton, Deputy Administrator at the Centers for Medicare & Medicaid Services and Director of the Center for Medicare and Medicaid Innovation (CMMI), about the strategic and practical realities of building a company in the Medicare space right now. Abe covers how CMS's new technology-focused payment models, including ACCESS and Geo AHEAD, are creating opportunities that did not previously exist for health tech innovators. He shares the founder-specific advice he wished he had when he was on the other side of the government-innovator divide: read the regulations, understand the intent behind the payment structures you are building on, and think twice before framing your CMS pitch as a small pilot. This conversation includes direct questions from StartUp Health community members representing companies across diagnostics, caregiving, digital therapeutics, rural health, and AI-powered clinical tools -- a small sample of the live Q&A from the original fireside chat. Getting a seat in that room, and direct access to the people shaping the future of healthcare, is one of the things StartUp Health community membership is built for. Learn more at startuphealth.com.

What if the most underused tool in health innovation communication was sitting right in your pocket? In this episode of StartUp Health NOW, recorded live at HLTH 2025 in Las Vegas, StartUp Health co-founder Unity Stoakes sits down with Dan Kendall, founder of Mission Based Media and the Health Podcast Library, for a candid conversation about the power of audio storytelling in healthcare. Dan shares why he built a podcast network after searching for health innovation content and finding almost nothing, how organizations of any size can start podcasting, and why the rise of AI is actually making authentic human voices more important than ever. They also dig into the Health Podcast Summit, a free resource Dan launched to help health communicators raise their voices at a moment when it matters most. Whether you're a founder, clinician, or health system leader, this episode will change how you think about reaching the people who need to hear your story. 🎧 Listen now and visit Mission Based Media to learn more about Dan's work. 🚀 Are you ready to tell YOUR story? Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and join today. 🎙️ Want to get started as a guest right here on StartUp Health NOW? Learn more about opportunities.

What if the most important moment in Alzheimer's care happened not in a neurologist's office, but at a routine primary care visit? That is the premise behind Cx Precision Medicine's NeuroFirst Memory, a blood-based triage test designed to help primary care physicians quickly determine whether a symptomatic patient's memory concerns warrant specialist referral or can be addressed right where care begins. In this Health Moonshot Update, StartUp Health co-founder Unity Stoakes speaks with Danguole Altman, CEO of CxPM, about the broken diagnostic pathway that leaves patients waiting years for answers, the science grounding NeuroFirst Memory in one of the largest multi-ethnic neurodegenerative disease datasets ever assembled, and what a smarter triage step could mean for patients, payers, and the future of precision medicine. 🧠 The structural failures driving the 3.5-year diagnostic delay🩸 How AI plus blood biomarkers power a scalable, primary care-ready triage tool ⏱️ Why the intervention window closes faster than most people realize 💰 The reimbursement strategy that keeps NeuroFirst Memory on the covered side of the line 🔬 A pipeline built for Parkinson's and Alzheimer's subtype diagnostics 🚀 CxPM's Series A and the road to broad clinical launch🌐 What even a seasoned entrepreneur can learn as a member of the StartUp Health Community

🔬 What does it actually take to get a health technology from the lab to the patient's hands? Gerald (Jerry) Wilmink, PhD, knows the journey firsthand. As a former startup founder, one-time Chief Business Officer at CarePredict (a StartUp Health community company), and now Director of Business Development and Licensing at Cleveland Clinic Innovations, Jerry has navigated nearly every stage of the health tech commercialization path. In this conversation with StartUp Health co-founder Unity Stoakes, Jerry shares how Cleveland Clinic Innovations evaluates new technologies, why the best partnerships happen early, and what today's AI tools are making possible for clinicians, researchers, and founders alike. From augmented reality rehab for Parkinson's patients to ambient AI scribing tools reducing physician burnout, this episode is a window into one of the world's leading health systems and how it turns invention into impact. 🎙️ Jerry Wilmink, PhD | Director of Business Development and Licensing, Cleveland Clinic Innovations 🎙️ Host: Unity Stoakes | Co-Founder, StartUp Health 🔔 Subscribe for weekly conversations with the innovators transforming health. --- Join Jerry Wilmink, PhD, for a Live AMA Next Week Want to ask your questions directly? On Tuesday, April 28, Jerry joins the StartUp Health community for a live Expert AMA session focused on health tech commercialization, AI in clinical care, and how leading health systems discover and adopt emerging technologies. He will share how Cleveland Clinic evaluates new technologies, what makes a startup partnership-ready, and where the biggest opportunities are right now in AI and digital health. Bring your questions. This is an exclusive session for StartUp Health community members. Join the community at startuphealth.com to get access and submit your questions in advance.

Julie Yoo has seen healthcare from nearly every angle, as a founder who scaled Kyruus to 20 million patients, as a board member, and now as a General Partner at a16z leading investments in some of the most consequential AI health companies being built today. In this conversation with StartUp Health co-founder Unity Stoakes and an interactive audience of StartUp Health community members, she unpacks the ideas she’s been putting forward publicly and the thinking behind them. Why will healthcare benefit from AI more than any other industry? What does infinite healthcare actually mean, and why did it generate such a polarized reaction? Why is she now actively encouraging the compound business model she once cautioned founders against? And what does she look for in a founder when everyone walking into a Series A looks the same on paper? A rich, candid conversation for anyone building, funding, or thinking deeply about the future of health. Do you want to participate in live conversations with industry luminaries? When you join StartUp Health – a private community for founders, investors, buyers, and industry leaders to connect year-round – you are invited to a full calendar of interactive Fireside Chats with the most influential leaders shaping health innovation. Come with questions, learn what is working right now, and connect with industry icons. » Learn more and join today.

What does it mean to build something that has never existed before? In this episode of StartUp Health NOW, Unity Stoakes sits down with CEO & Co-founder Valerie Gharagouzloo and Chief Science Officer & Co-founder Codi Gharagouzloo, PhD, of Imaginostics, the health technology company reimagining what MRI can tell us about the human body. Their platform, built on a technology invented by Codi during his PhD research in 2012, creates a new quantitative data layer inside existing MRI scanners, one that replaces toxic contrast agents, delivers images judged ten times better than the gadolinium standard, and generates vascular biomarkers measurable for the first time at the individual patient level. StartUp Health community members Valerie and Codi break down the difference between their two platforms, ImagiView™ and ImagiSight™, explain why blood-brain barrier leakage matters for Alzheimer’s and how they are finally able to measure it in individual patients, and share what their commercialization partnership with Siemens means for getting this technology into hospitals. Twice nominated for the Prix Galien, backed by four federal research agencies, and now running a 96-patient study funded by the Alzheimer’s Drug Discovery Foundation, Imaginostics is one of the most rigorously validated zero-to-one technologies in health innovation today.   Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, journal, and YouTube channel – is a benefit of our Health Moonshot Membership. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and join today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

What does it mean to build something that has never existed before? In this episode of StartUp Health NOW, Unity Stoakes sits down with CEO & Co-founder Valerie Gharagouzloo and Chief Science Officer & Co-founder Codi Gharagouzloo, PhD, of Imaginostics, the health technology company reimagining what MRI can tell us about the human body. Their platform, built on a technology invented by Codi during his PhD research in 2012, creates a new quantitative data layer inside existing MRI scanners, one that replaces toxic contrast agents, delivers images judged ten times better than the gadolinium standard, and generates vascular biomarkers measurable for the first time at the individual patient level. StartUp Health community members Valerie and Codi break down the difference between their two platforms, ImagiView™ and ImagiSight™, explain why blood-brain barrier leakage matters for Alzheimer’s and how they are finally able to measure it in individual patients, and share what their commercialization partnership with Siemens means for getting this technology into hospitals. Twice nominated for the Prix Galien, backed by four federal research agencies, and now running a 96-patient study funded by the Alzheimer’s Drug Discovery Foundation, Imaginostics is one of the most rigorously validated zero-to-one technologies in health innovation today. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, journal, and YouTube channel – is a benefit of our Health Moonshot Membership. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and join today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

What does it actually take to transform the way the world thinks about food as a driver of health? Kim Fisher has spent years finding out — as an entrepreneur, a startup mentor, a UC Davis program director, and now as Chief Impact Officer of StartUp Health’s Food as Medicine Moonshot. In this episode, Unity Stoakes and Kim go deep on the science, the market dynamics, and the human stories behind one of health innovation’s most complex and consequential frontiers. They explore the molecular science quietly reshaping how we understand food, why the GLP-1 moment may be the catalyst the industry has been waiting for, and how precision nutrition could soon mean personalized meals calibrated to your individual biology. Kim also opens up about the personal journey that brought her here — her daughter’s Type 1 diabetes diagnosis and the hospital conversation that made her realize just how far the healthcare system still had to go in treating food as medicine. That moment set the course for everything that followed. Listeners will come away with a clearer map of where the field is headed, what kinds of innovation are most needed, and how a new angel investment network is working to close the funding gap for early-stage food and health companies. If you’re a founder, investor, researcher, or policymaker working anywhere near food, metabolic health, or longevity — this conversation will sharpen your thinking. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, journal, and YouTube channel – is a benefit of our Health Moonshot Membership. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and join today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

What does it actually take to transform the way the world thinks about food as a driver of health? Kim Fisher has spent years finding out — as an entrepreneur, a startup mentor, a UC Davis program director, and now as Chief Impact Officer of StartUp Health’s Food as Medicine Moonshot. In this episode, Unity Stoakes and Kim go deep on the science, the market dynamics, and the human stories behind one of health innovation’s most complex and consequential frontiers. They explore the molecular science quietly reshaping how we understand food, why the GLP-1 moment may be the catalyst the industry has been waiting for, and how precision nutrition could soon mean personalized meals calibrated to your individual biology. Kim also opens up about the personal journey that brought her here — her daughter’s Type 1 diabetes diagnosis and the hospital conversation that made her realize just how far the healthcare system still had to go in treating food as medicine. That moment set the course for everything that followed. Listeners will come away with a clearer map of where the field is headed, what kinds of innovation are most needed, and how a new angel investment network is working to close the funding gap for early-stage food and health companies. If you’re a founder, investor, researcher, or policymaker working anywhere near food, metabolic health, or longevity — this conversation will sharpen your thinking.   Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, journal, and YouTube channel – is a benefit of our Health Moonshot Membership. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and join today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.  

Most healthcare AI conversations start and end with documentation. StartUp Health community member Mehmet Kazgan, CEO & Founder of cliexa, thinks that is the wrong place to focus. In this episode of StartUp Health NOW, Kazgan joins Unity Stoakes for a deep dive into clinical reasoning, the intelligence layer that connects what a patient says, what a provider decides, and what a payer will cover, all in real time. Kazgan traces the evolution of healthcare technology from EMRs to interoperability to AI scribes, and explains why none of those waves solve the core problem without a reasoning engine underneath. He shares what it took to build and validate that engine over eight years, what deploying it with Mayo Clinic Platform and Eating Recovery Center has revealed, and why the window for health systems to act is right now. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, journal, and YouTube channel – is a benefit of our Health Moonshot Membership. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and join today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.